The National Institutes of Health (NIH) awarded a research team at George Washington (GW), Yale, and Duke Universities $7.8 million to establish a rare disease network for Myasthenia Gravis.
- August 18, 2020A research project that received critical early funding from Duke CTSI is now ready to enter the $1.1 billion hernia market.
- July 08, 2020
The Duke CTSA KL2 program was recently identified as one of the top program hubs by the Center for Leading Innovation and Collaboration (CLIC). The Duke KL2 program was a top performer in the KL2 education program – Underrepresented measure. The CLIC evaluates programs using a Common Metrics Initiative. In alignment with the CLIC’s current goals, the Duke KL2 program set a goal to increase the
- -Wake Forest University Health SciencesThe Wake Forest Clinical and Translational Science Institute (CTSI) in conjunction with Duke and UNC would like to invite postdoctoral scholars and early career faculty involved in research to attend Research Resilience in the Age of COVID-19: Insights from Sponsors and Investigators on Thursday, July 9 from 2:00 - 4:30 pm. This virtual conference brings together researchers from all three
- -Duke University
Following the announcement of new FDA guidance on the conduct of clinical trials of medical products during the current COVID-19 pandemic, the Clinical Trials Transformation Initiative (CTTI) last week held a public call for experiences and insights from across clinical trials ecosystem. During this webinar, presenters will provide a summary of that aggregated feedback and offer best practices for
- University Of North Carolina Chapel HillDuke UniversityWake Forest University Health SciencesMedical University Of South CarolinaReGARDD provides academic researchers with the regulatory tools and resources necessary to successfully navigate the pathway from discovery to clinical implementation of new drugs, biologics and medical devices. Investigational New Drug or Biologic Investigational Device Exemption Educational Videos ReGARDD Sponsored Events Who We Are The Regulatory Guidance for Academic Research of Drugs and
- Duke University
The modern era of health analytics is built on data science. Data science merges computer science with statistics, creating new potential for extracting clinical insight from the exponentially increasing “big” data relevant to our patients’ health. Realizing this potential requires new capabilities and innovative technologies. For effective implementation in a healthcare setting, an Accelerator is
- -Duke University
The 11th Annual International Science of Team Science Conference is June 1-4, 2020 at Duke University in Durham, NC! SciTS 2020 will bring together team science practitioners, scholars, and providers from a broad range of disciplines to share and advance the latest evidence-based methods in team collaboration and transdisciplinary science. Speakers and attendees will include investigators
- Duke University
This training provides information regarding the sponsor and investigator requirements for an IND or IDE as well as resources to ensure compliance with FDA regulations. There are two separate training modules that each focus on the requirements for the specific regulatory application that the sponsor or sponsor-investigator holds. Sponsors who hold an IND (for drugs and biologics) can complete the
- Duke UniversityPrinciples and Techniques for Developing and Delivering Effective Scientific Presentations This video series was created, designed, and presented by Kevin Weinfurt, PhD and Steve Grambow PhD. The series starts with a brief introduction and has four major sections: Section 1 — Telling Your Story: Principles and techniques for effective scientific storytelling. Section 2 — Creating Slides
- Duke UniversityThe Regulatory Affairs Training Program is 6 weeks and consists of weekly discussions and lectures combined with independent study. There will be opportunities to review and discuss different types of regulatory submissions, including Investigational New Drug applications (INDs) and Investigational Device Exemptions (IDEs). Participants will also have the opportunity to attend an IRB meeting on